Miczone T 250mg/31.25mg Injection
Marketer
Medifaith Biotech
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Miczone T 250mg/31.25mg Injection
Tazicef 250mg/31.25mg injection combines two active ingredients to combat diverse bacterial infections. Administered only by a healthcare provider, this medication inhibits bacterial growth and spread. Complete the prescribed course, even with symptom improvement; premature cessation can reduce efficacy. Schedule adherence is crucial. Potential side effects include nausea, vomiting, diarrhea, and indigestion; worsening symptoms require immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, breathing difficulty). Inform your doctor of all medications before use, especially if pregnant or breastfeeding. Avoid alcohol due to potential increased drowsiness. While usually not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and hydration are essential for optimal recovery. Your physician may order tests to monitor treatment effectiveness.
Uses of Miczone T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Miczone T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Miczone T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Miczone T 250mg/31.25mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Miczone T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam (Miczone T 250mg/31.25mg Injection) combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial growth. The addition of Tazobactam counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Miczone T 250mg/31.25mg Injection use alongside alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Miczone T (250mg/31.25mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal to no negative impacts on fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
Miczone T 250mg/31.25mg injections require careful consideration during lactation. Mothers should discontinue breastfeeding throughout treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Miczone T 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Operating a vehicle should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Miczone T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Miczone T 250mg/31.25mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Miczone T 250mg/31.25mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Miczone T 250mg/31.25mg Injection :
Omit a scheduled Miczone T 250mg/31.25mg Injection? Seek medical advice immediately.
Facts to Know About Miczone T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently